Hemoglobin C (HbC) has been recently associated with protection against Plasmodium falciparum malaria. It is thought that HbC influences the development of immune responses against malaria, suggesting that the variation at the HbC locus (rs33930165) may interact with polymorphic sites in immune genes. We investigated, in 198 individuals belonging to 34 families living in Burkina Faso, statistical interactions between HbC and 11 polymorphisms within interleukin-4 (IL4), IL12B, NCR3, tumor necrosis factor (TNF) and lymphotoxin-a (LTA), which have been previously associated with malaria-related phenotypes. We searched for multilocus interactions by using the pedigree-based generalized multifactor dimensionality reduction approach. We detected 29 multilocus interactions for mild malaria, maximum parasitemia or asymptomatic parasitemia after correcting for multiple tests. All the single-nucleotide polymorphisms studied are included in several multilocus models. Nevertheless, most of the significant multilocus models included IL12B 3 0 untranslated region, IL12Bpro or LTA þ 80, suggesting that those polymorphisms play a particular role in the interactions detected. Moreover, we identified six multilocus models involving NCR3 that encodes the activating natural killer (NK) receptor NKp30, suggesting an interaction between HbC and genes involved in the activation of NK cells. More generally, our findings suggest an interaction between HbC and genes influencing the activation of effector cells for phenotypes related to mild malaria.
Introduction
Hemoglobin (Hb) variants have been shown to protect from clinical malaria. In particular, the protective effect of HbS (b6Glu4Val, rs334) is now well established. 1 More recently, the HbC mutation (b6Glu4Lys, rs33930165) has been associated with protection from severe malaria in Mali, Ghana and Burkina Faso, [2] [3] [4] although initial studies indicated lack of protection in Nigeria and in Mali. 5, 6 Modiano et al. 4 detected a 29% reduction in risk of clinical malaria in HbAC individuals, and a 93% reduction in risk of clinical malaria in HbCC individuals in a large population living in Burkina faso; this study provided evidence of protective effect against both mild and severe malaria. In the same way, we found that HbC carriers had less frequent mild malaria attacks than AA individuals in the same age group in a longitudinal study of individuals living in Burkina Faso, and that HbC was negatively associated with mild malaria and maximum parasitemia by using family-based association tests. 7 However, a large study conducted in Ghana failed to detect an association of HbC with mild malaria in children enrolled at 3 months. 8 In all, several studies indicated a protective effect of HbC, whereas other studies indicated a lack of association. These conflicting results may be explained by (i) different genetic backgrounds in the studied populations, (ii) different age groups studied, (iii) different malaria transmission intensities in different endemic areas, (iv) a lack of power in some studies because of the modest effect of HbC at the heterozygous stage (AC) and/or an insufficient sample size, (v) the existence of genetic interactions that were not taken into account. In addition, the conflicting results may be mainly due to gene-age, gene-environment or gene-gene interactions.
In spite of some conflicting results, it should be stressed that several association studies support the protective effect of HbC in human malaria. This is further supported by evidence of a positive selection, 9, 10 and by in vitro studies with human cells. [11] [12] [13] [14] Although the molecular mechanisms behind the protection remain to be elucidated, several mechanisms have been proposed: (i) a low capacity of the parasite to replicate in red blood cells; (ii) an altered expression of parasite antigens on the surface of red blood cells leading to a diminished cytoadhesion and/or an altered immune response; (iii) and an increased phagocytosis of the infected red blood cells. Several studies have demonstrated in vitro that the growth of the parasite was inhibited in CC cells, [12] [13] [14] whereas the parasite grows normally in AC cells. 12 Recently, Fairhurst et al. showed that AC and CC cells have a reduced capacity of adhesion to endothelial monolayers expressing CD36 and ICAM-1, rosetting interactions with non-infected red blood cells, and agglutination in the presence of pooled sera from malaria-immune adults, and an altered expression of PfEMP-1 on the membrane. These findings suggest that HbC may protect against cerebral malaria by inhibiting PfEMP-1-mediated sequestration in cerebral microvessels. The abnormal display of PfEMP-1 on AC and CC red blood cells also lead to a reduced CD36 phagocytosis of trophozoite-infected cells by blood monocytes, suggesting that HbC does not protect against malaria by enhancing phagocytosis. 15 However, HbC carriers have been found to produce increased levels of immunoglobulin-G directed against several plasmodial antigens, 16, 17 suggesting that HbC may increase antibodydependent phagocytosis or cytotoxicity, may accelerate naturally acquired immunity, and may interact with genes involved in immune responses. Besides, natural killer (NK) cells have been found to recognize PfEMP-1 at the surface of infected red blood cells via NKp30, 18 suggesting that the abnormal display of PfEMP-1 on AC and CC red blood cells may alter the activation of NK cells. One might suggest that malaria-related phenotypes are influenced by the interaction between HbC and genes encoding proteins produced by or acting on monocytes, NK cells, T and B lymphocytes. Genes that are located within chromosomal regions linked to mild malaria or parasitemia [19] [20] [21] and those that have been associated with mild malaria, parasitemia or severe malaria [22] [23] [24] are of particular interest for gene-gene interaction analyses.
In this report, we evaluated the statistical interaction between HbC and immune genes, which were previously associated with malaria-related phenotypes.
We detected gene-gene interactive effects for interleukin 4 (IL4), IL12B, tumor necrosis factor (TNF), NCR3 and LTA by using the pedigree-based generalized multifactor dimensionality reduction (PGMDR) method. 25 Results Table 1 summarizes the association results of the studied single-nucleotide polymorphisms (SNPs) with mild malaria, maximum parasitemia and asymptomatic parasitemia, and also reports previously published association studies. In addition, we assessed the family-based association of NCR3 and TNF polymorphisms with asymptomatic parasitemia, of LTA and IL12B polymorphisms with mild malaria and maximum parasitemia, and of IL4-590 with asymptomatic parasitemia, maximum parasitemia or mild malaria. We used marker information from previous studies for HBB, IL12B, TNF, NCR3 and LTA (Table 1) , while we genotyped IL4-590 polymorphism. In all, we found an association of LTA þ 80 with maximum parasitemia (Z ¼ 1.94; P ¼ 0.048), and an association of TNF-238 with asymptomatic parasitemia (Z ¼ 2.10; P ¼ 0.035). We did not detect other additional associations (Table 1) .
We assessed gene-gene interaction between rs33930165 (HBB A4C) on the one hand and 11 SNPs within several immune genes (Table 1) on the other hand by using PGMDR with adjustment for age. We searched for twolocus models that may explain variation in asymptomatic parasitemia, maximum parasitemia or mild malaria. Table 2 summarizes classification parameters calculated with the training set (odds ratio and P-value), the crossvalidation consistency, the prediction accuracy for the testing set and the sign test P-value for each significant two-locus model. We found cross-validation consistency across all significant models; prediction accuracy ranged from 0.56 to 0.62 for these models. Seven, five and two SNPs were found to interact with HBB for mild malaria, maximum parasitemia and asymptomatic parasitemia at the 0.05 nominal level, respectively. These included mostly several SNPs associated with one of these phenotypes. IL12Bpro, IL12B 3 0 untranslated region (3 0 UTR), TNF-863 and TNF-857 that were not found to be associated with mild malaria or maximum parasitemia interacted with rs33930165 for these phenotypes. Interestingly, HBB:IL12Bpro, HBB:TNF-1031 and HBB:TNF-238 were significant two-locus models for mild malaria and maximum parasitemia, whereas HBB:LTA þ 80 and HBB:TNF-308 were significant for mild malaria and asymptomatic parasitemia.
We further evaluated three-, four-and five-locus models containing rs33930165 (Table 3) . Table 3 shows the best models identified on the basis of the classification parameters with the training set and the crossvalidation analysis with the testing set (prediction accuracy and sign test P-value) for mild malaria, maximum parasitemia and asymptomatic parasitemia after applying a false discovery rate (FDR) of 5%. There was cross-validation consistency across all significant models. The statistical parameters of the multilocus models were better than those of the two-locus models. Although some two-locus P-values remained significant for either the training set statistics or the testing set statistics after applying a FDR of 5%, the two-locus models did not reach the significance threshold for both odds ratio and sign test P-values: HBB:TNF-308 and HBB:IL12Bpro were significant for mild malaria on the basis of the sign test, but were not significant on the basis of the odds ratio statistics (Table 2 ). In contrast, the multilocus models that showed a significant sign test P-value for the cross-validation analysis had a significant P-value for the odds ratio calculated with the training set, except for two SNP combinations (HBB:TNF-857:TNF-238: IL12Bpro and HBB:TNF1304:IL12B 3 0 UTR:IL12Bpro) when analyzing asymptomatic parasitemia (Table 3) . Each SNP was included in several significant multilocus models (nX4). IL12B 3 0 UTR, IL12Bpro and LTA þ 80 were included in 18, 14 and 13 of the multilocus models (n ¼ 29), respectively. IL4-590 and TNF-1031 were in 10 out of the 29 models, whereas NCR3-412 and SNPs within the TNF promoter were in more than 6 models. In all, 26 out of the multilocus models included IL12B 3 0 UTR or IL12Bpro, suggesting that they have a central role in gene-gene interactions. In all, 24 out of the 29 SNP combinations were identified for the three phenotypes on the basis of the training set statistics with a FDR of 5%, whereas there was no SNP combination associated with the three phenotypes on the basis of the testing set statistics with a FDR of 5% (Table 3) . At this significance level, all the SNP combinations were significant for mild malaria and maximum parasitemia (n ¼ 18), maximum parasitemia and asymptomatic parasitemia (n ¼ 9), or mild malaria and asymptomatic parasitemia (n ¼ 2) on the basis of the testing set statistics. Nevertheless, we identified 16 out of the 29 SNP combinations for the three phenotypes based on the testing set statistics after applying a FDR of 10% (Table 3) .
Discussion
The objective of this paper was to assess statistical epistasis between HbC (rs33930165) and genetic variants that are located in immune genes, and that may influence the level of gene expression. We applied PGMDR that allows adjustment for qualitative and quantitative covariates, and is applicable to dichotomous and quantitative traits in family-based study designs. To our best knowledge, this is the first comprehensive study of gene-gene interactions that provided evidence of epistatic interactions in human malaria in a familial study.
We evaluated two-, three-, four and five-locus interactions involving HbC. We initially detected several significant two-locus models at the 0.05 nominal level, suggesting that HbC may interact with NCR3, TNF, LTA and IL12B polymorphisms. However, those were no more models that reached the significance threshold on two different statistics after applying a FDR of 5%; the Significant P-value after correcting for multiple testing.
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A Atkinson et al first statistics was based on odds ratio calculated with the training set, whereas the second statistics was based on a cross-validation sign test calculated with the testing set. Furthermore, we focused on the models that showed an association with at least two malaria phenotypes, because we found strong correlations between mild malaria and maximum parasitemia on the one hand, and between maximum parasitemia and asymptomatic parasitemia on the other hand; the correlation between mild malaria and asymptomatic parasitemia was also significant. On this basis, we identified significant 29 three-, four-or five-locus models, which contained all the SNPs studied. Most of the multilocus models included IL12B 3 0 UTR, IL12Bpro or LTA þ 80, suggesting that those polymorphisms have a particular role in the interactions detected. Interestingly, significant multilocus models involved SNPs that were not associated with mild malaria, maximum parasitemia or asymptomatic parasitemia in the population studied: these are TNF-863 and TNF-857 within TNF, 24 IL12Bpro and IL12B 3 0 UTR within IL12B, 26 and IL4-590. Nevertheless, TNF-863, TNF-857, IL12Bpro and IL12B 3 0 UTR have been associated with severe malaria, [27] [28] [29] [30] and IL4-590 has been associated with antibody levels in malaria-infected individuals. 31, 32 The statistical epistatic interactions that we detected may correspond to interactions on the biological level. Here we propose that the statistical interactions reflect the effect of allelic combinations on the activation of effector cells, such as NK cells, monocytes or B lymphocytes. We detected six multilocus models containing NCR3-412 located within the promoter of NCR3, which encodes the activating NK receptor NKp30. This is in line with the accumulating evidence of an important role of NK cells in human malaria. 33, 34 NK cells are among the first blood cells to produce interferon-g in response to P. falciparum-infected red blood cells, and this production requires contact between NK cells and P. falciparuminfected red blood cells. 35, 36 The NK receptors and the parasite ligands that are involved in the NK activation are poorly known. Recently, Mavoungou et al. 18 reported that NKp30 binds to PfEMP-1 at the surface of infected red blood cells, and that this interaction mediates cytolysis of P. falciparum-infected red blood cells. Baratin et al. 36 found that PfEMP-1 also binds to ICAM-1, and that this interaction was mandatory for NK cell interferon-g response. In contrast, D'Ombrain et al. 37 found that PfEMP-1 suppresses interferon-g production by peripheral blood mononuclear cells, and that the loss of PfEMP-1 fails to impact cytolosis-associated LAMP-1 surface translocation. These conflicting results imply that the molecular basis of NK activation needs further investigation. They are, however, consistent with the hypothesis that the variation in HBB influences both the display of PfEMP-1 and the activation of NK cells. The multilocus models involving HbC and NCR3-412 included a combination of the following polymorphisms: TNF-1031, TNF-857, TNF-308, TNF-238, LTA þ 80, IL4-590, IL12Bpro and IL12B 3 0 UTR. As IL12 is a potent activator cytokine for NK cells, 38 IL12Bpro and IL12B 3 0 UTR that are thought to influence the production of IL12 in monocytes may influence the activation of NK cells. In contrast, IL4 inhibits both the cytotoxicity and the cytokine production in NL cells, 39 and IL4-590 that alters the production of IL4 in T lymphocytes may also reduce the inhibition effect. TNF and LTA that are produced by activated NK cells activate the effector functions of monocytes; TNF and LTA can be viewed as activation markers for NK cells, [40] [41] [42] and as activating molecules for monocytes. 41 In addition, TNF-1031, TNF-857, TNF-308, TNF-238 and LTA þ 80, which are cis-regulatory polymorphisms, may influence both the production of TNF and LTA in activated NK cells and the ability of monocytes to eliminate the parasite. It should be stressed that TNF is also produced by monocytes and T lymphocytes, whereas LTA is produced by Th1 lymphocytes. 43 This suggests that TNF and LTA polymorphisms may also act on malaria phenotypes independently of NK cells. In this way, we provided evidence of significant multilocus models that did not contain NCR3-412. In particular, we identified 11 multilocus combinations that contained LTA þ 80, all the TNF SNPs studied, IL4-590, IL12Bpro and IL12B 3 0 UTR, and 12 multilocus combinations that contained the TNF SNPs studied, IL4-590, IL12Bpro and IL12B 3 0 UTR. Although genetic variation in TNF and LTA likely influences the activation of monocytes, the molecular basis of HbC-TNF and HbC-LTA interaction effects on malaria phenotypes remains, nevertheless, unclear. In contrast, HbC has been shown to influence the production of immunoglobulin-G directed against malarial antigens, 16,17 suggesting an interaction between HbC and genes involved in the activation of B lymphocytes and/or the Th1/Th2 balance, such as IL4 and IL12B. Taken together, our findings support the hypothesis that cis-regulatory polymorphisms within immune genes influence the activation of effector cells and phenotypes related to mild malaria, and that their effects could be altered by genetic variation in HBB locus.
The HBB locus was recently shown to be a major locus associated with severe malaria on the basis of a genome-wide one-locus association study in Africa. 44 The authors detected a strong association signal at the HbS variant, and did not detect any significant associations at other locus, suggesting that the effect of other genes was very small. Our findings suggest that the effect of other genes on severe malaria may depend on the genetic variation at the HBB locus. Interestingly, HbC, the frequency of which reaches high values in West Africa, is close to HbS; HbC and HbS mutations are located within the same codon. Although the issue is still debated, it is thought that HbC and HbS may share some effects, such as enhanced immune responses. 17, [45] [46] [47] Further studies on genetic interaction between HbC and HbS on the one hand and immune genes on the other hand may help to unravel the genetic control of severe malaria.
In conclusion, our main findings are that HbCimmune genes interactions influences mild malaria, maximum parasitemia and asymptomatic parasitemia, and that multilocus interactions better explain the variation in the phenotypes. These statistical interactions suggest the existence of biological interactions involving HbC. Our findings support the hypothesis that HbC influences the protective immune response in individuals living in malaria endemic areas. Symmetrically, the protective effect of HbC may depend on the genotypes at other locus. Therefore, our findings may partly explain the conflicting results concerning the protective effect of HbC in human malaria.
Materials and methods

Subjects and phenotype determination
The study population consisted of 198 individuals belonging to 34 families living a urban district of Bobo Dioulasso in Burkina Faso, in which infected mosquitoes were detected only during August, September and October; the numbers of infective bites per person and per year was 30. Phenotypes and DNA were available for all the individuals. The mean age of sibs was 12.1 þ 6.2 years (range 1-34 years). The study population and the area of parasite exposure have been described. 48, 49 The Medical Authority of Burkina Faso approved the study protocol.
Febrile episodes were extensively recorded by active case detection during 24 months. For patients with fever, a thick blood film was prepared by the standard procedures. Diagnosis of mild malaria attack was based on P. falciparum parasitemia, fever (axillary temperature more than 37.5 1C) and clinical symptoms (headache, aching, vomiting or diarrhea in the children); in that case no threshold of parasitemia was used. In the absence of classical symptoms of malaria, and once others pathologies could not be eliminated, only children (ageo15 years) with more than 5000 parasites per ml and older subjects with more than 2000 parasites per ml were considered as having had a malaria attack. Each episode of illness was treated according to the recommendation of the CNRFP (Centre National de Recherche et Formation sur le Paludisme) of Burkina Faso. Parasitemia was checked at the end of the treatment. Subjects who presented at least one mild malaria attack during the survey were considered in the analysis affected, whereas the others were considered unaffected. Determination of parasitemia was described in our previous study. 48 Briefly, each family was visited 20 times during the 24 months of the study and parasitemia was measured. In addition, parasitemia was measured during febrile episodes. The mean number of parasitemia measurements per subject was 15.2±5.1 (range 1-24). Fingerprint peripheral blood samples were taken from all family members present, and thick and thin blood films were stained with Giemsa. The parasite determination and numeration were established blindly from two independent readings. Only P. falciparum asexual forms were retained to determine parasitemia. Parasitemia was defined as the number of parasitized erythrocytes observed per ml in thin blood films.
Maximum parasitemia was based on a logarithmic transformation of the highest parasitemia that was measured in each individual during the survey. Mean of adjusted asymptomatic parasitemia was a logarithmic transformation of the parasitemia adjusted for seasonal transmission 48 after excluding parasitemia during febrile episodes. To take into account the seasonality of the transmission, the influence of the date of the visits on ln(1 þ parasitemia) (LP) was evaluated by one way analysis of variance. The mean LP observed during each visit was calculated. The individual LP was then corrected for the visit effect by subtracting from each individual LP the mean LP of the corresponding visit.
Logistic regression analyses that took into account the effect of age showed a strong positive correlation between mild malaria and maximum parasitemia (Po0.0001) and a positive correlation between mild malaria and asymptomatic parasitemia (P ¼ 0.013). A linear regression analysis that took into account the effect of age showed a positive correlation between maximum parasitemia and asymptomatic parasitemia (Po0.0001).
Genotyping
Blood samples were taken by venipuncture. The Hb genotypes were identified by electrophoresis of red blood cell lysates on acetate membrane at an alkaline pH. Acetate sheets were stained with ponceau red. This yielded discrimination of Hbs A, S and C.
DNA was extracted from mononuclear cells separated by the Ficoll-Hypaque density gradient as described. 21 Samples were first subject to prior whole-genome amplification by primer extension preamplification. 50 For NCR3, TNF, LTA and IL12B polymorphisms, we used the data sets previously reported. [22] [23] [24] 26 IL4-590 C/T genotypes was determined by using PCR and allele-specific restriction enzyme digestion methods as previously described. 51 The PCR products were digested with the restriction enzymes BsmFI (New England Biolabs Inc., Ipswich, MA, USA), resulting in two fragments of 192 and 60 bp for the 590C allele and an intact (252 bp) product for the 590 T allele. Digestion products were analyzed by electrophoresis on a 3% agarose gel stained by ethidium bromide. In addition, sequencing was performed to control the genotype of 10 individuals. Briefly, the PCR products were purified with the Qiagen QIAquick PCR purification kit (Qiagen, Courtaboeuf, France) and quantified by 2% agarose gel electrophoresis. Sequencing reaction was performed with the CEQ 8000 kit and a CEQ 8000 automated fluorescent sequencer (Beckman Coulter, Roissy CDG, France). All the genotypes were confirmed by sequencing.
Family-based association and interaction analyses
We carried out family-based association analyses using the family-based association test approach. This approach avoids biases because of the population stratification, population heterogeneity or population admixture. 52 The family-based association test statistics, which uses data from sibships in nuclear families, takes into account sibling correlations. The default null hypothesis is no linkage and no association. The statistics under this hypothesis calculated the distribution of offspring genotypes that are conditional on parental genotypes and on trait values. We calculated a Z-score and a two-side P-value based on a normal distribution, and also empirical P-values based on 100 000 permutations.
Gene-gene interactions between HbC and other SNPs located within NCR3, TNF, LTA, IL4 and IL12B were analyzed by using PGMDR. 25 Table 1 presents the SNPs that were selected on the basis of their association with malaria phenotypes. [22] [23] [24] [27] [28] [29] [30] [31] [32] 46, [53] [54] [55] [56] [57] The PGMDR is a score-based multifactor dimensionality reduction method that uses the same data reduction strategy as does the original multifactor dimensionality reduction method to detect nonlinear genetic interactions, 58 that is to classify multilocus genotype combinations as high risk or low risk ones. The original multifactor dimensionality reduction method uses the ratio of cases and controls to identify the combinations of genotypes that show the strongest association with the phenotype. The generalized multifactor dimensionality reduction approach uses statistical scores that replace the ratio of cases and controls to discriminate between high risk and low risk genotype combinations, allowing to analyze both qualitative and quantitative phenotypes, and to take into account covariates. 59 The PGMDR method extends the generalized multifactor dimensionality reduction one, and offers handling different family types and sizes as well as patterns of missing data. 25 Briefly, we used a 10-fold cross-validation procedure. The informative sibs were randomly divided into nearly 10 nearly equal subsets, and the cross-validation was repeated 10 times. Each time, nine subsets were used as the training set, whereas the last subset was considered the testing set. We used a linear regression model and a logistic regression model for the quantitative traits (maximum parasitemia and asymptomatic parasitemia) and the dichotomous trait mild malaria, respectively; this allowed us to take into account age as a covariate to calculate the scores. Statistical scores were calculated for each genotype combination on the basis of the training set, leading to label high risk and low risk genotype combinations; high risk and low risk genotype combinations were further pooled into separate groups, creating a binary model. The classification accuracy was calculated for the training set, and the odds ratio, the corresponding 95% confidence interval and the P-value were calculated. The model that had the maximum classification accuracy was chosen as the best. The consistency of the model was tested 10 times; it corresponded to the number of times that a given attribute combination was selected as the best model. The testing set was used to estimate the prediction accuracy of the best model, which is the ratio of correct classifications to the total number of instances classified; because cross-validation was used, this value was estimated from the average of all accuracies across the 10 subsets. We used the non-parametric sign test to evaluate the significance of the prediction accuracy. Multiple test corrections were further performed using the FDR method for odds ratio and sign test P-values; 60 we applied a FDR of 5 or 10%.
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